A cerebrospinal fluid (CSF) differential is ideally based on 100 identifiable nucleated cells—but low-cellularity specimens do not always provide that many. When the entire usable cytospin area contains fewer than 100 cells, the correct response is not to invent, duplicate, or “round up” cells. Count the cells that are actually present, document the denominator, and follow your laboratory’s validated standard operating procedure (SOP).

Why Low-Cell CSF Differentials Are Challenging

Normal CSF contains very few nucleated cells. Even when the chamber count shows nucleated cells, only a limited number may survive processing and appear intact on the cytospin slide. Cell loss, degeneration, uneven distribution, delayed processing, small specimen volume, and cytocentrifuge effects can all reduce the number of cells available for identification.

A differential based on fewer than 100 cells has greater sampling uncertainty. One cell represents 1% in a 100-cell count, but it represents 2% in a 50-cell count and 5% in a 20-cell count. For this reason, the total number of cells counted is essential context.

Practical Step-by-Step Approach

1. Confirm the specimen and preparation. Verify the tube number, specimen appearance, collection time, processing time, cytospin settings, stain quality, and any dilution used.
2. Scan the complete cellular deposit. Start at low power to locate the cytospin area and assess distribution. Use higher magnification for identification; use oil immersion when your SOP or morphology requires it.
3. Count every identifiable nucleated cell available. Classify cells consistently as neutrophils, lymphocytes, monocytes/macrophages, eosinophils, and other reportable cells according to local policy.
4. Do not count debris or cells that cannot be identified reliably. Degenerated cells may be described in a comment when clinically or analytically relevant, but they should not be forced into a category.
5. Repeat the cytospin only when justified. A repeat may help if preparation quality was poor and enough specimen remains. Repeating a well-prepared slide from a truly paucicellular sample may produce the same limitation and consume valuable CSF.
6. Escalate significant findings. Suspected malignant cells, blasts, atypical cells, organisms, or other critical morphology should follow the laboratory’s pathologist-review and critical-notification policy.

How Should Fewer Than 100 Cells Be Reported?

CLSI guidance for body-fluid cellular analysis recommends including the number of cells counted when the differential is based on fewer than 100 cells. The exact LIS format varies by laboratory. Some systems report percentages with a comment; others report the cells observed or use a limited-differential format.

For a hypothetical 50-cell differential containing 2 neutrophils, 43 lymphocytes, 4 monocytes, and 1 eosinophil, the calculated distribution is:

• Neutrophils: 4%
• Lymphocytes: 86%
• Monocytes: 8%
• Eosinophils: 2%

The key is to report that the denominator was 50 cells. A percentage without the denominator can appear more precise than the observation really is.

When a Differential May Be Unsuitable

A numerical differential may be unreliable or impossible when only a few cells are present, most cells are severely degenerated, the cellular deposit is lost or poorly stained, or morphology cannot be interpreted confidently. In these situations, follow the SOP for qualitative reporting, repeat preparation, supervisory review, or referral.

Do not automatically convert a technically inadequate preparation into a numerical differential. The report should communicate the limitation clearly.

Common Errors to Avoid

• Counting the same cells twice while moving across the cytospin area
• Including bare nuclei, stain precipitate, platelets, or debris as nucleated cells
• Forcing severely degenerated cells into a leukocyte category
• Reporting percentages without stating that fewer than 100 cells were counted
• Repeating the preparation multiple times without considering specimen volume and urgency
• Failing to escalate suspicious malignant cells or microorganisms

Key Takeaway

When a CSF cytospin contains fewer than 100 identifiable cells, count what is genuinely present, state the actual number counted, document any important limitation, and apply your laboratory’s validated SOP. Transparency is more accurate—and more clinically useful—than creating false precision.

Educational note: This article supports laboratory learning and does not replace your institution’s validated procedure, accreditation requirements, medical director guidance, or pathologist review policy.

References

• CLSI H56: Body Fluid Analysis for Cellular Composition
• CAP TODAY Q&A: Body-fluid specimen handling and cell counts
• Performance Evaluation of Body Fluid Cellular Analysis Using the Sysmex XN
• Effect of Sample Processing and Time Delay on CSF Cell Count

Related learning: Review more hematology and clinical microscopy resources on MLS Ultimate Hub, then test yourself using the body-fluid and morphology practice questions.